Levels of triglycerides, cholesterol, LDL, HDL and glucose in patients with schizophrenia, unipolar depression and bipolar disorder

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 9, Issue 3, 2015, Pages 168-176

  Wysokiński, Adam ^a   Strzelecki, Dominik ^a   Kłoszewska, Iwona ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Bipolar disorder; Depression; Glucose; Lipid profile; Schizophrenia

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX RATIO; YOUNG ADULT; BLOOD; COMPLICATION; CROSS-SECTIONAL STUDY; DEPRESSION; METABOLIC DISORDER; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; BIPOLAR DISORDER; BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; METABOLIC DISEASES; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SCHIZOPHRENIA; TRIGLYCERIDES;

EID: 84937514454     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2015.04.004     Document Type: Article

References (22)

1. C.U. Correll, A.M. Frederickson, J.M. Kane, and P. Manu Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs J Clin Psychiatry 67 2006 575 583
2. M.A. De Hert, R. van Winkel, D. Van Eyck, L. Hanssens, M. Wampers, A. Scheen, and et al. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication Schizophr Res 83 2006 87 93
3. P.J. Teixeira, and F.L. Rocha The prevalence of metabolic syndrome among psychiatric inpatients in Brazil Rev Bras Psiquiatr 29 2007 330 336
4. R.S. McIntyre, K.Y. Park, C.W. Law, F. Sultan, A. Adams, M.T. Lourenco, and et al. The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications CNS Drugs 24 2010 741 753
5. S. Maumus, B. Marie, G. Siest, and S. Visvikis-Siest A prospective study on the prevalence of metabolic syndrome among healthy french families: two cardiovascular risk factors (HDL cholesterol and tumor necrosis factor-alpha) are revealed in the offspring of parents with metabolic syndrome Diabetes Care 28 2005 675 682
6. O. Sidorenkov, O. Nilssen, T. Brenn, S. Martiushov, V.L. Arkhipovsky, and A.M. Grjibovski Prevalence of the metabolic syndrome and its components in Northwest Russia: the Arkhangelsk study BMC Public Health 10 2010 23
7. A.J. Mitchell, D. Vancampfort, K. Sweers, R. van Winkel, W. Yu, and M. De Hert Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders - a systematic review and meta-analysis Schizophr Bull 39 2013 306 318
8. M. Yumru, H.A. Savas, E. Kurt, M.C. Kaya, S. Selek, E. Savas, and et al. Atypical antipsychotics related metabolic syndrome in bipolar patients J Affect Disord 98 2007 247 252
9. A. Wysokiński, M. Kowman, and I. Kłoszewska The prevalence of metabolic syndrome and Framingham cardiovascular risk scores in adult inpatients taking antipsychotics - a retrospective medical records review Psychiatr Danub 24 2012 314 322
10. K.G. Alberti, P. Zimmet, and J. Shaw Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation Diabetes Med 23 2006 469 480
11. W.P. Castelli, R.D. Abbott, and P.M. McNamara Summary estimates of cholesterol used to predict coronary heart disease Circulation 67 1983 730 734
12. J. de Leon, M.T. Susce, M. Johnson, M. Hardin, L. Pointer, G. Ruano, and et al. A clinical study of the association of antipsychotics with hyperlipidemia Schizophr Res 92 2007 95 102
13. C.M. Alexander, P.B. Landsman, S.M. Teutsch, and S.M. Haffner NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older Diabetes 52 2003 1210 1214
14. N. Richter, G. Juckel, and H.J. Assion Metabolic syndrome: a follow-up study of acute depressive inpatients Eur Arch Psychiatry Clin Neurosci 260 2010 41 49
15. A. Sicras-Mainar, M. Blanca-Tamayo, J. Rejas-Gutierrez, and R. Navarro-Artieda Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: a cross-sectional assessment of a primary health care database Eur Psychiatry 23 2008 100 108
16. V. Vaccarino, C. McClure, B.D. Johnson, D.S. Sheps, V. Bittner, T. Rutledge, and et al. Depression, the metabolic syndrome and cardiovascular risk Psychosom Med 70 2008 40 48
17. L.S. Kinder, M.R. Carnethon, L.P. Palaniappan, A.C. King, and S.P. Fortmann Depression and the metabolic syndrome in young adults: findings from the Third National Health and Nutrition Examination Survey Psychosom Med 66 2004 316 322
18. D.C. Goff, L.M. Sullivan, J.P. McEvoy, J.M. Meyer, H.A. Nasrallah, G.L. Daumit, and et al. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls Schizophr Res 80 2005 45 53
19. D. Mozaffarian, A. Kamineni, R.J. Prineas, and D.S. Siscovick Metabolic syndrome and mortality in older adults: the Cardiovascular Health Study Arch Intern Med 168 2008 969 978
20. F. Misawa, K. Shimizu, Y. Fujii, R. Miyata, F. Koshiishi, M. Kobayashi, and et al. Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects? A cross-sectional study BMC Psychiatry 11 2011 118
21. S.S. Smith, and M.C. Fiore The epidemiology of tobacco use, dependence, and cessation in the United States Prim Care 26 1999 433 461
22. G.E. Schuitemaker, G.J. Dinant, G.A. van der Pol, and J.W. van Wersch Relationship between smoking habits and low-density lipoprotein-cholesterol, high-density lipoprotein-cholesterol, and triglycerides in a hypercholesterolemic adult cohort, in relation to gender and age Clin Exp Med 2 2002 83 88